EMERGENCY CARE OF CRISIS CONDITIONS IN MYASTHENIA GRAVIS
https://doi.org/10.24884/2072-6716-2019-20-2-25-30
Abstract
The article presents an analysis of current data on emergency management of crises in patients with myasthenia gravis, which is supplemented by our own observations of 892 patients with myasthenia gravis. A follow-up study was conducted, which helped us to assess the frequency, nature and course of crises in patients with myasthenia gravis, taking into account the form of the disease, sex and age of patients. It was found that crises were observed in 154 (17.4%) patients, these conditions were significantly more often registered at the age of 20 to 40 and in the first three years of the disease. Myasthenic crises 149 (96.9%) prevailed among the crises and were registered mainly in patients with generalized and pharyngeal-facial myasthenia. Based on long-term follow-up of patients and assessment of the results of emergency management of myasthenic crises we have presented an optimal scheme for prescription of anticholinesterase medicines as a part of combined therapy of crises of varying severity.
About the Authors
S. V. Lobzin
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
Sergej V. Lobzin
St. Petersburg
M. G. Sokolova
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
Mariya G. Sokolova
St. Petersburg
V. A. Shavurov
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
Vadim A. Shavurov
St. Petersburg
A. A. Zuev
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
Andrej A. Zuev
St. Petersburg
References
1. Sepp Е. K., Lancova V. B. Miasteniya. Moscow: Izdatel’stvo Nevromed, 2008, 112 p. (in Russ.)
2. Miasteniya: diagnostika i lechenie / pod red. S. V. Lobzina. Saint Petersburg: Izdatel’stvo SpecLit, 2015. 160 p. (in Russ.)
3. Sanadze A. G. Miasteniya i miastenicheskie sindromy: rukovodstvo dlya vrachej. Moscow: Izdatel’stvo Litera, 2012. 256 p. (in Russ.)
4. Kosachev V. D. Optimizaciya diagnostiki, lecheniya i prognozirovaniya miastenii: avtoref. dis… d-ra. med. nauk. Saint Petersburg, 2007. 44 p. (in Russ.)
5. Alshekhlee A., Miles J. D., Katirji B., Preston D. C., Kaminski H. J. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals // Neurology. 2009. No 72. Р. 1548–1554. doi: 10.1212/wnl.0b013e3181a41211.
6. Kotov S. V., Sidorova O. P. Iskhody i lechenie miastenicheskogo kriza. Zhurnal nevrologii i psihiatrii, 2016, No 11, рр. 103–105 (in Russ.).
7. Prikaz Minzdrava Rossii ot 24.12.2012 g. No 1538 Н (in Russ.)]. (www.minzdrav.gov-murman.ru)
8. Shcherbakova N. I., Miroshkin Z. V. Mesto ciklosporina (sandimmuna neorala) v strategii i taktike lecheniya tyazhelyh form miastenii. Patogenez. 2010, No 8, рр. 65–66 (in Russ.).
9. Sanders D.B., Wolfe G. I., Narayanaswami P. Developing treatment guidelines for myasthenia gravis // Ann. N. Y. Acad. Sci. 2018. No 1412(1). Р. 95–101. doi: 10.1111/nyas.13537.
10. Chaudhuri A., Behanq P. O. Myasthenic crisis // Q. J. Med. 2009. No 102. Р. 97–107. doi: 10.1093/qjmed/hcn152.
Review
For citations:
Lobzin S.V., Sokolova M.G., Shavurov V.A., Zuev A.A. EMERGENCY CARE OF CRISIS CONDITIONS IN MYASTHENIA GRAVIS. EMERGENCY MEDICAL CARE. 2019;20(2):25-30. (In Russ.) https://doi.org/10.24884/2072-6716-2019-20-2-25-30
Views:
5209
Email this article 